MeSH term | MeSH ID | Detail |
---|---|---|
Edema | D004487 | 152 associated lipids |
Ear Diseases | D004427 | 7 associated lipids |
Glycyrrhetinic acid is a lipid of Prenol Lipids (PR) class. Glycyrrhetinic acid is associated with abnormalities such as Congenital Abnormality, Cortisol 11-beta-ketoreductase deficiency, Hypertensive disease, Mineralocorticoid Excess Syndrome, Apparent and Syndrome. The involved functions are known as Signal, Muscle Contraction, Pressure- physical agent, Agent and Metabolic Inhibition. Glycyrrhetinic acid often locates in Protoplasm, Body tissue, Muscle, Connexon and Extracellular. The associated genes with Glycyrrhetinic acid are SLC33A1 gene, GJB1 gene, RNU1-1 gene, HADHA gene and RNU1-4 gene. The related lipids are Steroids, Saponin, Octanols, Heptanol and amyrin.
To understand associated biological information of Glycyrrhetinic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glycyrrhetinic acid is suspected in Hypertensive disease, Kozlowski Celermajer Tink syndrome, Hypernatremia, Leishmaniasis, Visceral, Congenital Abnormality, Cortisol 11-beta-ketoreductase deficiency and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glycyrrhetinic acid
MeSH term | MeSH ID | Detail |
---|---|---|
Edema | D004487 | 152 associated lipids |
Ear Diseases | D004427 | 7 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kuang P et al. | 18β-glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in mice. | 2013 | Int. J. Cancer | pmid:22991231 |
Dygai AM et al. | Comparison of specific activity of granulocytopoiesis stimulators after treatment with cytostatics with different mechanisms of action. | 2013 | Bull. Exp. Biol. Med. | pmid:24288726 |
Li N et al. | Simultaneous determination of oleanolic acid, p-coumaric acid, ferulic acid, kaemperol and quercetin in rat plasma by LC-MS-MS and application to a pharmacokinetic study of Oldenlandia diffusa extract in rats. | 2012 Nov-Dec | J Chromatogr Sci | pmid:22718742 |
Li J et al. | The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid. | 2012 | J Drug Target | pmid:22577855 |
Nafisi S et al. | Interaction of glycyrrhizin and glycyrrhetinic acid with DNA. | 2012 | DNA Cell Biol. | pmid:22074129 |
Mu Y et al. | Visual input modulates audiomotor function via hypothalamic dopaminergic neurons through a cooperative mechanism. | 2012 | Neuron | pmid:22920259 |
Gui M et al. | [Effect of glycyrrhetinic acid on the expression of inflammatory factors in fibroblast-like synovial cells from collagen induced arthritis rats]. | 2012 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:22980653 |
Behringer EJ et al. | Electrical conduction along endothelial cell tubes from mouse feed arteries: confounding actions of glycyrrhetinic acid derivatives. | 2012 | Br. J. Pharmacol. | pmid:22168386 |
Zhang C et al. | Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. | 2012 | Biomaterials | pmid:22169820 |
Li S et al. | A novel transdermal fomulation of 18β-glycyrrhetic acid with lysine for improving bioavailability and efficacy. | 2012 | Skin Pharmacol Physiol | pmid:22832704 |